January 31, 2022 – FLT3 inhibitors enhance radiosensitivity in radioresistant prostate cancer cells

This last event leads to pro-tumoral effects counterbalancing the anti-tumoral ramifications of FAK phosphorylation inhibition, detailing why FAK shRNA transduction didn’t influence survival and proliferation in the SCLC cell lines we examined

Post author:abic2004
Post published:January 31, 2022
Post category:Urokinase-type Plasminogen Activator

This last event leads to pro-tumoral effects counterbalancing the anti-tumoral ramifications of FAK phosphorylation inhibition, detailing why FAK shRNA transduction didn't influence survival and proliferation in the SCLC cell lines…